Gimv (GIMBB) Stock Overview

A private equity and venture capital firm specializing in direct and fund of funds investments. More details

GIMBB fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	0/6
Past Performance	2/6
Financial Health	4/6
Dividends	2/6

Rewards

Trading at 42.6% below our estimate of its fair value

Earnings have grown 11.5% per year over the past 5 years

Risk Analysis

High level of non-cash earnings

Shares are highly illiquid

Dividend of 4.32% is not well covered by free cash flows

GIMBB Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View all narratives

Gimv NV Competitors

Price History & Performance

Summary of share price highs, lows and changes for Gimv
Historical stock prices
Current Share Price	€44.35
52 Week High	€48.95
52 Week Low	€44.35
Beta	0.51
1 Month Change	-9.30%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	2.42%
5 Year Change	-18.25%
Change since IPO	19.90%

Recent updates

Shareholder Returns

	GIMBB	GB Capital Markets	GB Market
7D	0%	0.4%	1.1%
1Y	n/a	-10.5%	18.0%

Return vs Industry: Insufficient data to determine how GIMBB performed against the UK Capital Markets industry.

Return vs Market: Insufficient data to determine how GIMBB performed against the UK Market.

Price Volatility

Is GIMBB's price volatile compared to industry and market?
GIMBB volatility
GIMBB Average Weekly Movement	n/a
Capital Markets Industry Average Movement	4.4%
Market Average Movement	5.4%
10% most volatile stocks in GB Market	10.8%
10% least volatile stocks in GB Market	3.0%

Stable Share Price: GIMBB's share price has been volatile over the past 3 months compared to the UK market.

Volatility Over Time: Insufficient data to determine GIMBB's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1980	95	Koen Dejonckheere	www.gimv.com/en/

Gimv NV is a private equity and venture capital firm specializing in direct and fund of funds investments. For direct investments, the firm specializes in buyouts, growth capital, pre-revenue, middle market, debt, shareholder loans, seed, startups, early to mid-stage, mezzanine, late venture, emerging growth, public to private transactions, small and medium sized enterprises, later stage, mature, replacement capital, bridge financing, and recapitalization. Within fund of funds, it seeks to invest in venture capital and private equity funds.

Gimv NV Fundamentals Summary

How do Gimv's earnings and revenue compare to its market cap?
GIMBB fundamental statistics
Market cap	€1.66b
Earnings (TTM)	€231.08m
Revenue (TTM)	€302.10m

7.2x

P/E Ratio

5.5x

P/S Ratio

Is GIMBB overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
GIMBB income statement (TTM)
Revenue	€302.10m
Cost of Revenue	€13.55m
Gross Profit	€288.55m
Other Expenses	€57.46m
Earnings	€231.08m

Last Reported Earnings

Dec 31, 2025

Next Earnings Date

Sep 03, 2026

Earnings per share (EPS)	6.29
Gross Margin	95.51%
Net Profit Margin	76.49%
Debt/Equity Ratio	17.5%

How did GIMBB perform over the long term?

See historical performance and comparison

Dividends

4.3%

Current Dividend Yield

41%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/06/27 12:28
End of Day Share Price	2026/06/19 00:00
Earnings	2025/12/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Gimv NV is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Olivier Van Doosselaere	BNP Paribas
Alexi Gantelme	BNP Paribas
Kris Kippers	Degroof Petercam

Gimv (GIMBB) Stock Overview

Rewards

Risk Analysis

Gimv NV Competitors

Rathbones Group

Bridgepoint Group

Law Debenture

Georgia Capital

Price History & Performance

Recent News & Updates

Less than half of directors are independent

Gimv NV, Annual General Meeting, May 27, 2026

Gimv NV to Report First Half, 2026 Results on Sep 03, 2026

Ipsen S.A. (ENXTPA:IPN) completed the acquisition of ImCheck Therapeutics SAS from Kurma Partners SA, Gimv NV (ENXTBR:GIMB) and others.

Gimv NV (ENXTBR:GIMB) signed an definitive agreement to acquire an unknown minority stake in Equine Care Group from Compagnie Nationale a Portefeuille SA.

Gimv NV to Report Fiscal Year 2025 Final Results on Mar 30, 2026

Recent updates

Less than half of directors are independent

Gimv NV, Annual General Meeting, May 27, 2026

Gimv NV to Report First Half, 2026 Results on Sep 03, 2026

Ipsen S.A. (ENXTPA:IPN) completed the acquisition of ImCheck Therapeutics SAS from Kurma Partners SA, Gimv NV (ENXTBR:GIMB) and others.

Gimv NV (ENXTBR:GIMB) signed an definitive agreement to acquire an unknown minority stake in Equine Care Group from Compagnie Nationale a Portefeuille SA.

Gimv NV to Report Fiscal Year 2025 Final Results on Mar 30, 2026

Gimv NV to Report Nine Months, 2026 Results on Feb 19, 2026

Gimv NV to Report First Half, 2026 Results on Nov 20, 2025

Ipsen S.A. (ENXTPA:IPN) entered into a definitive share purchase agreement to acquire ImCheck Therapeutics SAS from Kurma Partners SA, Gimv NV (ENXTBR:GIMB) and others for €1.4 billion.

Gimv NV (ENXTBR:GIMB) entered into an agreement to acquire an unknown majority stake in Novicare B.V. from Gilde Healthcare Partners BV.

Gimv NV (ENXTBR:GIMB) and the management of Hemink Groep B.V. completed the acquisition of an unknown majority stake in Hemink Groep B.V. from management and Pontex Investment Partners.

Gimv NV (ENXTBR:GIMB) and the management of Hemink Groep B.V. agreed to acquire an unknown majority stake in Hemink Groep B.V. from its former management and Pontex Investment Partners.

Gimv NV and the management of Alpine Nederland B.V. acquired an unknown majority stake in Alpine Nederland B.V. from Vendis Capital, founders and management of Alpine Nederland B.V.

Cobepa S.A. acquired an unknown majority stake in Itineris NV from Participatiemaatschappij Vlaanderen NV, Gimv Arkiv II a fund managed by Gimv NV (ENXTBR:GIMB), SmartFin Capital I a fund managed by SmartFin Capital NV and Federal Holding and Investment Company.

Bugaboo International B.V. acquired an unknown minority stake in Joolz from Gimv NV (ENXTBR:GIMB).

Gimv NV to Report Fiscal Year 2025 Results on May 22, 2025

Gimv NV agreed to acquired as unknown majority stake in The Spice Factory from Gilde Equity Management and Davy De Muyer.

Gimv NV (ENXTBR:GIMB) acquired an unknown minority stake in Robojob NV.

B+N Referencia Zrt. agreed to acquire an unknown majority stake in Köberl Group from Gimv NV (ENXTBR:GIMB).

Gimv NV, Eric Merilhou, Yann Dauce and the management of Tibbloc acquired an unknown majority stake in Tibbloc from Ciclad, SAS.

Gimv NV (ENXTBR:GIMB) and Wolf D. Koch agreed to acquire an unknown majority stake in Lupine Lighting Systems GmbH from Wolf D. Koch.

Fremman Limited agreed to acquire an unknown majority stake in rehaneo GmbH from Gimv NV (ENXTBR:GIMB).

The Martens Brewery of Bocholt acquired United Dutch Breweries B.V. from Gimv NV (ENXTBR:GIMB) and management.

BiZZdesign BV agreed to acquire MEGA International S.A. from Gimv NV (ENXTBR:GIMB).

WorxInvest NV completed the acquisition of 27.81% stake in Gimv NV (ENXTBR:GIMB) from Flemish Community.

Sagard SAS acquired Groupe Acceo from Gimv NV (ENXTBR:GIMB).

Gimv NV to Report Fiscal Year 2024 Results on May 23, 2024

Crédit Mutuel Equity signed an agreement to acquire unknown majority stake in Groupe CLAIRE SAS from Gimv NV (ENXTBR:GIMB).

Insufficient new directors

Insufficient new directors

Full year 2023 earnings released: €2.20 loss per share (vs €6.59 profit in FY 2022)

Insufficient new directors

Insufficient new directors

Insufficient new directors

Insufficient new directors

Insufficient new directors

Insufficient new directors

Gimv NV to Report Fiscal Year 2023 Results on May 17, 2023

Gimv NV, Annual General Meeting, Jun 28, 2023

Insufficient new directors

Insufficient new directors

Insufficient new directors

Insufficient new directors

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Insufficient new directors

Insufficient new directors

Full year 2021 earnings released: EPS €7.96 (vs €5.96 loss in FY 2020)

New 90-day high: €51.00

New 90-day high: €50.70

Shareholder Returns

Price Volatility

About the Company

Gimv NV Fundamentals Summary

Earnings & Revenue

Dividends

Company Analysis and Financial Data Status

Data Sources

Analysis Model and Snowflake

Industry and Sector Metrics

Analyst Sources